|
|
Volumn 27, Issue 4, 2009, Pages 303-
|
|
RIP Raptiva?
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
EFALIZUMAB;
MONOCLONAL ANTIBODY;
CHEMICALLY INDUCED DISORDER;
HUMAN;
MORTALITY;
NOTE;
POSTMARKETING SURVEILLANCE;
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY;
PSORIASIS;
RISK ASSESSMENT;
UNITED STATES;
ANTIBODIES, MONOCLONAL;
HUMANS;
LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL;
PRODUCT SURVEILLANCE, POSTMARKETING;
PSORIASIS;
RISK ASSESSMENT;
UNITED STATES;
|
|
EID: 67049109667
PISSN: None
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0409-303 Document Type: Note |
|
Times cited : (4)
|
|
References (0)
|
